Loading
A phase 2 trial of Intraoperative fluorescence and Cerenkov imaging systems in Prostate cancer, run by Intuitive Surgical, completed.
IS-002 Phase 2 Prostate Cancer Study is a phase 2 interventional study registered as NCT05946603 by Intuitive Surgical, with 59 participants recorded, started 2023-06-16 and reaching its primary completion in 2024-05-21. Interventions recorded: Administration of IS-002, Firefly fluorescent imaging, robotic-assisted laparoscopic prostatectomy with pelvic lymph node dissection. Conditions recorded: Prostate Cancer.
Linked to the technology Intraoperative fluorescence and Cerenkov imaging systems because the registry names it ("firefly") among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/